Tag: Ginkgo BioWorks

Genomatica Magica – $90 Million Financing, Commercialized Technologies, Biobased Nylon

Genomatica Magica – $90 Million Financing, Commercialized Technologies, Biobased Nylon

October 21, 2018 |

Bioengineering…it doesn’t sound very magical but it is full of mystery and potential waiting to be unlocked, much like Harry Potter’s character. In the early books and movies, Harry is young, mysterious, smart, and you just know he is capable of something great and destined for amazing things. We feel the same about bioengineering and […]

Read More

Ginkgo’s insane $275M venture haul says it loud: Digital Biology is here

Ginkgo’s insane $275M venture haul says it loud: Digital Biology is here

December 14, 2017 |

Last week we shared with you a framework for a rising technology wave — we called it Digital Biology, the convergence of digital and biological technology waves that is changing genetics from an artisan’s niche into a branch of information technology. More evidence of the power of the Digital Biology wave arrives this week with […]

Read More

Amyris teams with Ginkgo Bioworks on new cultured ingredients

Amyris teams with Ginkgo Bioworks on new cultured ingredients

September 15, 2016 |

In California, Amyris announced that it has completed a subsequent collaboration agreement with Ginkgo Bioworks, which is expected to be approved by the boards of both companies. The agreement finalizes details of how the two companies will jointly develop cultured products more efficiently and cost effectively, accelerating time to market. This breakthrough biotech collaboration was […]

Read More

Amyris busts a move: major deals with Givaudan, Ginkgo

Amyris busts a move: major deals with Givaudan, Ginkgo

June 29, 2016 |

Zombies with attitude. New partnerships for making magic molecules and exploitin’ the heck out of ’em. These days, nothing in Hollywood beats a great zombie movie, more than 50 have been released in recent years. Zombies rise from the dead, and change everything around them. It’s not always pretty, or predictable, but they’re a disruptive force. […]

Read More

Ginkgo BioWorks raises $45M in monster Series B venture round

Ginkgo BioWorks raises $45M in monster Series B venture round

July 23, 2015 |

In Massachusetts, Ginkgo Bioworks has raised $45 million in an oversubscribed Series B round. Viking Global, a firm managing more than $30 billion in capital, led the round along with previous investors including OS Fund, Y Combinator and Felicis Ventures. The new funds will be used to expand into new categories such as pharmaceuticals, cosmetics and probiotics, as […]

Read More